Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms 1Adenocarcinoma, Mucinous 1

Interventions

Mitomycin 2Capecitabine 2Tacrolimus 1Specimen Handling 1Sirolimus 1Nivolumab 1Magnetic Resonance Spectroscopy 1Lansoprazole 1Ipilimumab 1Hyperthermic Intraperitoneal Chemotherapy 1Cytoreduction Surgical Procedures 1Clarithromycin 1CTLA-4 Antigen 1Bromelains 1Amoxicillin 1Alemtuzumab 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pseudomyxoma Peritonei × Bromelains × Clear all
NCT03976973 2022-03-15

BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei

Mucpharm Pty Ltd

Phase 2 Unknown
62 enrolled

Adenocarcinoma, Mucinous, Pseudomyxoma Peritonei, Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡